Declaration of Statement of deviation or variation under Regulation 32 of SEBI (LODR) Regulations, 2015

Date: November 13, 2026 Asst. General Manager, Dept. of Corporate Services, BSE Limited 1st Floor, P.J. Towers, Dalal Street, Fort, Mumbai: 400001. Sub: Submission of Statement of Deviation(s) or Variation(s) pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Reference: CLINITECH LABORATORY LIMITED (CTLLAB) Scrip Code: 544220. Dear Sir, Pursuant to Regulation 32(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed a statement showing any deviation or variation as on September 30, 2026 from utilization of funds raised through public issue. Kindly take the document on record and acknowledge the receipt. Thanking you, Yours faithfully, For CLINITECH LABORATORY LIMITED Jagdish Umakant Nayak Chairman and Managing Director DIN: 00646672 Encl: as above STATEMENT OF DEVIATION / VARIATION IN UTILISATION OF FUNDS RAISED Name of listed entity CLINITECH LABORATORY LIMITED Mode of Fund Raising Public Issue (IPO) Date of Raising Funds 30-07-2024 (Allotment date) Amount Raised INR 578.30 Lakhs Report filed for Quarter ended September 30, 2026 Monitoring Agency Not applicable Monitoring Agency Name, if applicable Not applicable Is there a Deviation / Variation in use of funds No Deviation or Variation raised If yes, whether the same is pursuant to change Not applicable in terms of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval Not applicable Explanation for the Deviation / Variation Not applicable Comments of the Audit Committee after None review Comments of the auditors, if any None Objects for which funds have been raised and where there has been a deviation, in the following table: Original Modified Object, Original Modified Funds Amount of Remarks if Object if any Allocation allocation, Utilised Deviation/Variati any (INR in if any (INR in on for the quarter lakhs) lakhs) according to applicable object Expansion - 498.67 0.00 448.67 NIL Allocation of fully utilised Diagnostic for the Centres disclosed purpose General - 41.33 0.00 41.33 NIL Allocation Corporate fully utilised Purposes for the disclosed purpose Issue 38.30 0.00 38.30 NIL Allocation related - fully utilised expenses for the disclosed purpose Total 578.30 0.00 528.30 NIL Total IPO proceeds are fully utilised for the disclosed purpose Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc For CLINITECH LABORATORY LIMITED Jagdish Umakant Nayak Chairman and Managing Director DIN: 00646672